The population-based prospective cohort analysis of adults who were members of a single U.S. health care delivery system compared CHD risk among those with and without a history of diabetes or CHD.
The authors stated that the impact of prediabetes awareness on the odds of adopting risk-reducing lifestyle factors highlights the special influence of physician input on patient behavior.
A “virtual clinic” model involving consultations between diabetes subspecialists and primary care physicians was associated with glycemic improvements in treated patients and controls from the same practices, a British study found.
Patients who were under age 55 faced a more substantial increase in mortality risk from having diabetes than older patients.
When added to metformin, DPP-4 inhibitors were associated with reduced risks for all-cause death and stroke but did not appear to alter the risks for myocardial infarction and hospitalization for heart failure relative to sulfonylureas.
Once-weekly glucagon-like peptide 1 (GLP-1) receptor agonists lower HbA1c without increasing body weight, a review found.
More patients would be eligible for metformin use if estimated glomerular filtration rate were used to define kidney disease rather than serum creatinine, a recent study concluded.
The estimated prevalence of diabetes among U.S. adults ranged between 12% and 14% in 2011-2012, according to a recent study.
Home use of a closed-loop insulin delivery system, or artificial pancreas, appeared to be effective in patients with type 1 diabetes, according to 2 recently published reports conducted under regular living conditions.
Pioglitazone was not found to be associated with a statistically significant increased risk of bladder cancer or 8 of 10 additional cancers in a recent study.